A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

Conditions: NonSegmental Vitiligo Interventions: Drug: Povorcitinib; Drug: Placebo Sponsors: Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Study | Vitiligo